Show simple item record

dc.contributor.authorCarrillo-Larco, R.M.
dc.contributor.authorPearson-Stuttard, J.
dc.contributor.authorBernabe-Ortiz, A.
dc.contributor.authorGregg, E.W.
dc.date.accessioned2025-10-31T18:33:52Z
dc.date.available2025-10-31T18:33:52Z
dc.date.issued2020
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5027
dc.description.abstractBackground: Body mass index (BMI) has increased in Latin-America, but the implications for the diabetes burden have not been quantified. We estimated the proportion and absolute number of diabetes cases attributable to high BMI in Bolivia, Ecuador and Peru (Andean Latin-America), with estimation of region-level indicators in Peru. Methods: We estimated the population attributable fraction (PAF) of BMI on diabetes (regardless of type 1 or 2) from 1980 to 2014, including the number of cases attributable to overweight (BMI 25–<30), class I (30–<35), class II (BMI 35–<40) and class III (BMI ≥ 40) obesity. We used age- and sex-specific prevalence estimates of diabetes and BMI categories (NCD-RisC and Peru's DHS survey) combined with relative risks from population-based cohorts in Peru. Findings: Across Andean Latin-America in 2014, there were 1,258,313 diabetes cases attributable to high BMI: 209,855 in Bolivia, 367,440 in Ecuador and 681,018 in Peru. Between 1980 and 2010, the absolute proportion of diabetes cases attributable to class I obesity increased the most (from 12.9% to 27.2%) across the region. The second greatest increase was for class II obesity (from 3.6% to 16.5%). There was heterogeneity in the fraction of diabetes cases attributable to high BMI by region in Peru, as coastal regions had the largest fractions, and so did high-income regions. Interpretation: Over one million diabetes cases are attributable to high BMI in Andean Latin-America. Public health efforts should focus on implementing population-based interventions to reduce high BMI and to develop focused interventions targeted at those at highest risk of diabetes.en_US
dc.description.sponsorshipRodrigo M. Carrillo-Larco has been supported by Strategic Award, Wellcome Trust-Imperial College Centre for Global Health Research ( 100693/Z/12/Z ), and Imperial College London Wellcome Trust Institutional Strategic Support Fund [Global Health Clinical Research Training Fellowship] ( 294834/Z/16/Z ISSF ICL ). Rodrigo M Carrillo-Larco is supported by a Wellcome Trust International Training Fellowship ( 214185/Z/18/Z ).
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElsevier Ireland
dc.relation.ispartofurn:issn:1872-8227
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectInnovative Approaches in Diabetes Management and Monitoringen_US
dc.subjectDiabetes Risk Assessment and Prevention Strategiesen_US
dc.titleThe Andean Latin-American burden of diabetes attributable to high body mass index: A comparative risk assessmenten_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1016/j.diabres.2019.107978
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.18
dc.type.otherResearch article
dc.identifier.journalDiabetes Research and Clinical Practice
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2